Matthew R. Sydes
MRC Clinical Trials Unit at UCL(GB)University College London(GB)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life, Meta-analysis and systematic reviews
Most-Cited Works
- → Practical methods for incorporating summary time-to-event data into meta-analysis(2007)6,330 cited
- → Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial(2015)1,944 cited
- → Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy(2017)1,740 cited
- → Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial(1999)1,375 cited
- → Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial(2018)1,235 cited
- → Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial